Close

Interviews

Untapping the potential of saponin based vaccine adjuvants

An interview with Gaston Salinas, CEO, Botanical Solution Inc. regarding BSI’s unique approach for developing a robust and truly sustainable supply chain for QS-21. Q 1. How did this idea of growing Quillaja saponaria trees within the laboratories come into play? BSI scientists...

DISCOVERING EFFECTIVE MEANS OF ADVANCING THE CLINICAL TRIALS ARENA

In this Q&A session with Dr. Christina Brennan, Senior Vice President for Clinical Research at Northwell Health, we learn about the benefits of Greenphire's ClinCard in simplifying and automating patient reimbursements. Furthermore, she highlights the importance of implementing a...

Enabling Inventory Optimization Function – The nVentic Way

One of the leading inventory management companies, nVentic has been a force to reckon with as it has time and again helped its clients with double digit reductions when it comes to inventories and has also aided in maintaining...

Emma Rhodes, Head of Research and Development at Sterling, talks women and girls in science

With women underrepresented within the science, technology, engineering and math industries (STEM), here, Emma Rhodes (pictured), Head of Research and Development at Sterling Pharma, talks about her journey into a STEM career. Firstly, can you tell us about how you...

AI Based Drug Discovery & Development – Not a long shot anymore

How artificial intelligence and technology have had an impact on everything from research and development to clinical trials, helping to shape the direction that drugs will take in the future was recently answered in detail to World Pharma Today's...

Interview on Financial Lifestyle Management for Clinical Trials with Greenphire

Greenphire, the global leader when it comes to financial lifecycle management for clinical trials, recently announced the appointment of its new Chief Financial Officer, Owen Newman. Owen, who is adept in operations and financial management, comes with a rich experience of 25...

Developing a systematic quality approach for injectable drug products

For prefilled drug delivery systems – from a syringe to a complex wearable – the main goal of the aseptic manufacturing process is to prevent contamination of the final product and ensure that it fits for its intended use....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read